枢纽基因及其对伯基特淋巴瘤预后的关键影响
Yan-Feng Xu1, Guan-Yun Wang1, Ming-Yu Zhang1
1Department of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
World journal of clinical oncology
|November 16, 2023
概括
这项研究确定了CXCL10和IL2RA作为伯基特淋巴瘤 (BL) 的潜在预后标志物. 这些基因可能有助于预测患者的结果,并指导针对性治疗这种侵略性的B细胞癌症.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 伯基特淋巴瘤 (BL) 是一种具有迅速进展的侵袭性B细胞瘤.
- 目前的BL治疗缺乏标准化的方案,需要生物标志物的发现来预后和治疗选择.
- 公共可用的基因表达数据为BL的新诊断和治疗目标的识别提供了资源.
研究的目的:
- 为了确定伯基特淋巴瘤中关键的枢纽基因.
- 对已识别的枢纽基因进行基因本体学 (GO) 和生存分析.
- 为BL患者预后建立一个预测模型.
主要方法:
- 使用权重基因共同表达网络分析 (WGCNA) 来识别来自BL患者表达特征的基因模块.
- 该cytoHubba工具在显著的模块中识别了枢纽基因.
- 进行了基因本体学,基因和基因组的京都百科全书,蛋白质-蛋白质相互作用和遗传相互作用网络分析. 总体生存分析和名录构造被用来评估预后价值.
主要成果:
- WGCNA确定了8个基因模块,黄色模块与患者年龄有显著的相关性.
- 鉴定出了10个枢纽基因,包括SRC,TLR4,CD40,STAT3,SELL,CXCL10,IL2RA,IL10RA,CCR7和FCGR2B. 这些基因包括SRC,TLR4,CD40,STAT3,SELL,CXCL10,IL2RA,IL10RA和FCGR2B.
- 在BL患者中,CXCL10和IL2RA与整体存活 (OS) 有显著的关联. 开发了一种包含这些基因和年龄的诺米克图. 建议针对IL2RA和CXCL10的药物在复发/耐药BL中发挥潜在的治疗作用.
结论:
- 鉴定出CXCL10和IL2RA是伯基特淋巴瘤的潜在预后标志物.
- 这些基因可能有助于预测患者的预后并指导BL的治疗策略.
- 需要进一步研究向CXCL10和IL2RA的治疗潜力.
相关概念视频
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


